Back
ProShares S&P Kensho Cleantech ETF Vs. Monopar Therapeutics, Inc. Sector Stock Comparison
Sell
45
CTEX
ProShares S&P Kensho Cleantech ETF
Last Price:
$36.65
Seasonality Move:
-8.49%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$65.70
Seasonality Move:
25.93%
Sell
45
ProShares S&P Kensho Cleantech ETF (CTEX)
is a Sell
Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?
-
The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $35.27. The Score for CTEX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
CTEX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTEX Stock Price Chart
What is ProShares S&P Kensho Cleantech ETF's stock price today?
-
The ProShares S&P Kensho Cleantech ETF share price today is $35.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $67.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
CTEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 46.87 | Sell |
| Chaikin Money Flow: | -1917 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.65 - 37.27) | Sell |
| Bollinger Bands (100): | (26.66 - 36.66) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.86 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -124010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.34 - 86.38) | Sell |
| Bollinger Bands (100): | (44.81 - 88.99) | Buy |
CTEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.04 | Sell |
| 20-day SMA: | 35.49 | Sell |
| 50-day SMA: | 36.04 | Sell |
| 200-day SMA: | 25.62 | Buy |
| 8-day EMA: | 36.51 | Sell |
| 20-day EMA: | 36.2 | Sell |
| 50-day EMA: | 34.56 | Buy |
| 200-day EMA: | 20.7 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Sell |
| 20-day SMA: | 80.22 | Sell |
| 50-day SMA: | 82.77 | Sell |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 74.03 | Sell |
| 20-day EMA: | 77.79 | Sell |
| 50-day EMA: | 77.58 | Sell |
| 200-day EMA: | 56.47 | Buy |
ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
ProShares S&P Kensho Cleantech ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||